Shree Ganesh Remedies Limited (SGRL) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE414Y01015
Key metrics
- Market Cap
- ₹700 Cr
- P/E Ratio
- 45.3
- EPS
- 12.03
- Book Value
- 126.95
- P/B Ratio
- 4.29
- ROE
- 10.9%
- ROCE
- 12.94%
- Debt / Equity
- 0.19
- Net Margin
- 16.43%
- Revenue Growth
- 1.49%
- Profit Growth
- -23.01%
- Dividend Yield
- —
- 52W High
- ₹759.00
- 52W Low
- ₹381.10
- Market Cap Band
- small cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals. In addition, the company offers customized chemistry and manufacturing; assets and infrastructure; and customized processes of pharmaceutical chemicals. It also exports its products. The company serves life sciences, flavor and fragrance, polymer industries, electronics, and agro chemicals markets. Shree Ganesh Remedies Limited was incorporated in 1995 and is headquartered in Ankleshwar, India.
- Headquarters
- Ankleshwar, India
- Employees
- 224
- Promoter Holding
- 75.92%
The full Shree Ganesh Remedies Limited analysis
Create a free account to open the complete SGRL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.